Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us

    Medical Device Hazard analysis following ISO 14971

    View: 60

    Website https://www.compliance4all.com/webinar/medical-device-hazard-analysis-following-iso-14971-503503LIVE | Edit Freely

    Category

    Deadline: February 03, 2021 | Date: February 03, 2021

    Venue/Country: Online event, U.S.A

    Updated: 2020-12-28 20:14:41 (GMT+9)

    Call For Papers - CFP

    Overview:

    The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA also expects a post production risk management program be implemented.

    FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.

    One of the techniques described in ISO 14971 is Hazard Analysis. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools.

    In this webinar we will explain in detail the process of conducting a hazard analysis. The confusing terms "hazard", hazardous situation", "harm", "causative event", "ALARP", "risk index", "benefit/ risk ratio", and "residual risk" will be explained.

    We will go step by step through a template for risk analysis so that the process is clear. Examples of hazards and hazardous situations will be discussed. How to deal with residual risk will be discussed.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.